213.50EUR+1.09%Mkt Cap: 14.15B EURP/E: 87.19Last update: 2026-05-14
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometr…
Industry Peers
Medical Instruments & Suppliesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)87.19
P/E (Forward)32.03
PEG0.94
P/B5.23
P/S3.98
EV/EBITDA21.03
EV/Revenue5.36
EPS (TTM)2.36
EPS (Forward)6.40
Cash Flow & Leverage
FCF Yield2.21%
FCF Margin8.81%
Operating CF837.00M EUR
CapEx (TTM)441.90M EUR
Net Debt/EBITDA4.12
Net Debt3.73B EUR
Technical
SMA 50217.60 (-1.9%)
SMA 200225.64 (-5.4%)
Beta1.40
S&P 52W Chg24.23%
Avg Vol (30d)93.18K
Avg Vol (10d)89.44K
Technical Indicators
RSI (14)45.0
MACD-2.0788
MACD Signal-1.0596
MACD Hist.-1.0192
BB Upper242.23 EUR
BB Middle221.49 EUR
BB Lower200.75 EUR
BB Width18.73%
ATR (14)9.536 EUR
Vol Ratio (20d)1.05x
52W Range
175.9541% of range267.70
52W High267.70 EUR
52W Low175.95 EUR
Profitability
Gross Margin46.26%
EBITDA Margin25.48%
Profit Margin4.38%
Oper. Margin17.11%
ROE5.72%
ROA1.59%
Revenue Growth1.80%
Earnings Growth—
Balance Sheet
Debt/Equity1.58
Current Ratio0.91
Quick Ratio0.45
Book Value/Sh39.20 EUR
Cash/Share8.310 EUR
Dividends
Fwd Div Rate0.7400 EUR
Trail. Div Rate0.7400 EUR
Div. Yield0.36%
5Y Avg Yield0.32%
Payout Ratio31.49%
Ex-Div DateMar 27, 2026
Pay Date—
Splits
Last Split4:1
Split DateJun 13, 2016
Ownership
Shares Out.34.81M
Float27.45M
Insiders25.61%
Institutions31.95%
Analyst Consensus
Rating1.9 (Buy)
Target (Mean)264.42 EUR
Target Range190.00 EUR – 307.00 EUR
# Analysts19
Company
Market Cap14.15B EUR
Enterprise Value19.04B EUR
Revenue (TTM)3.55B EUR
Gross Profit1.64B EUR
Net Income (TTM)154.90M EUR
Revenue/Share51.24 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees14.2K
Last Price213.50 EUR
CountryDE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINDE0007165631